Exein, an embedded cybersecurity company focused on protecting connected devices, has raised €100M to expand what it calls a “digital immune system” designed to detect and stop attacks directly on devices operating in high-stakes environments such as hospitals and critical infrastructure.
The round was led by Blue Cloud Ventures, according to the company’s announcement. Exein says the funding will accelerate product development and deployment across the rapidly growing universe of connected systems—ranging from industrial sensors and medical devices to consumer electronics—at a time when cyberattacks increasingly target the physical world.
Why Exein is framing cybersecurity as a “digital immune system”
Exein’s pitch centers on the idea that modern devices need built-in, always-on protection that functions more like an immune response than a traditional perimeter defense. In practice, that means security capabilities embedded at the device level—where software meets hardware—rather than relying solely on network tools that may not see what’s happening inside constrained or remote endpoints.
The company’s “digital immune system” concept is aimed at monitoring device behavior, identifying anomalies, and helping stop malicious activity before it escalates into service disruption, data theft, or safety incidents. This approach matters because many connected endpoints operate with limited computing resources, long lifecycles, and infrequent patching—conditions that can leave them exposed for years.
As the number of connected endpoints climbs, the attack surface expands with it. Exein’s announcement highlights an ambition to help protect “2B+” people—an indicator of how widely connected devices are deployed across essential services and everyday life.
Cyberattacks are increasingly hitting hospitals and infrastructure
The fundraising arrives amid heightened concern about cyberattacks that disrupt real-world operations. Healthcare organizations have been repeatedly targeted by ransomware and extortion campaigns that can delay care, divert ambulances, and force hospitals to revert to manual procedures. In parallel, utilities and industrial operators face threats that can interrupt services or compromise safety systems.
Connected devices are often central to these environments: infusion pumps, imaging systems, patient monitors, building-management controllers, industrial gateways, and smart sensors. Many of these endpoints were not originally designed with modern threat models in mind, and they may be difficult to patch quickly due to regulatory constraints, uptime requirements, or vendor dependencies.
That reality has pushed security teams to look beyond traditional tools and invest in protections that can be deployed closer to the device itself—especially where downtime is unacceptable and where compromised endpoints can create cascading operational risks.
What the €100M round signals about the market
A €100M raise for an embedded security specialist underscores investor appetite for solutions addressing the security gap created by the Internet of Things and connected operational technology. While enterprise security spending has long prioritized servers, laptops, and cloud workloads, organizations are now grappling with fleets of endpoints that don’t behave like conventional IT assets.
Exein’s positioning aligns with several market forces:
- IoT security is moving from optional to mandatory as connected devices proliferate in regulated and safety-critical settings.
- Governments and regulators are pushing for stronger baseline security in products, increasing pressure on manufacturers and operators.
- Attackers are shifting toward targets that maximize disruption, leverage, and monetization—especially in healthcare and critical infrastructure.
By backing Exein, Blue Cloud Ventures is effectively betting that security embedded into devices—and scalable across heterogeneous hardware—will become a standard requirement rather than a premium add-on.
How embedded security fits into device manufacturing and operations
Unlike security tools that are installed after devices are deployed, embedded approaches are often designed to integrate earlier in the lifecycle. For device makers, that can mean incorporating security components during development and ensuring protections persist throughout production, deployment, and maintenance.
For operators, embedded protection can reduce reliance on compensating controls such as network segmentation alone—useful, but not always sufficient when devices communicate across complex environments or require remote access for maintenance.
Exein’s “digital immune system” framing suggests a focus on resilience: the ability to withstand attacks, limit blast radius, and maintain safe operation even when parts of the environment are compromised. In critical settings, that emphasis can be as important as preventing breaches outright.
What customers typically look for in connected-device security
In sectors like healthcare and industrial operations, security teams often prioritize:
- Low performance overhead on constrained devices
- Compatibility across diverse hardware and operating systems
- Clear visibility into device behavior and risk
- Support for long device lifecycles and complex patching realities
- Evidence that protections can meet regulatory or procurement requirements
Exein’s new capital is likely to be used to scale these capabilities, expand integrations, and accelerate adoption across more device categories and geographies.
What comes next for Exein after the funding
With €100M in fresh financing, Exein is positioned to invest in broader deployment of its embedded security model, deepen R&D, and pursue partnerships across the connected-device ecosystem. In practical terms, that could include closer collaboration with device manufacturers, platform providers, and operators responsible for large fleets of endpoints.
The company’s emphasis on protecting hospitals and infrastructure also suggests a go-to-market focus on sectors where the cost of disruption is highest and where buyers are increasingly mandated to demonstrate robust security controls.
For a world racing to connect everything—from clinical equipment to industrial machinery—the next phase will test whether embedded, immune-system-style defenses can scale fast enough to keep pace with attackers who have already proven they’re willing to target the systems people rely on most.
Dailyza will continue tracking how Exein deploys this capital and whether its device-level approach becomes a broader blueprint for securing the connected economy.